全文获取类型
收费全文 | 367篇 |
免费 | 28篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 8篇 |
妇产科学 | 8篇 |
基础医学 | 65篇 |
口腔科学 | 6篇 |
临床医学 | 26篇 |
内科学 | 79篇 |
皮肤病学 | 2篇 |
神经病学 | 29篇 |
特种医学 | 48篇 |
外科学 | 18篇 |
综合类 | 11篇 |
预防医学 | 21篇 |
眼科学 | 1篇 |
药学 | 17篇 |
中国医学 | 1篇 |
肿瘤学 | 65篇 |
出版年
2023年 | 2篇 |
2022年 | 6篇 |
2021年 | 7篇 |
2020年 | 2篇 |
2019年 | 7篇 |
2018年 | 3篇 |
2017年 | 3篇 |
2016年 | 9篇 |
2015年 | 8篇 |
2014年 | 8篇 |
2013年 | 16篇 |
2012年 | 7篇 |
2011年 | 6篇 |
2010年 | 12篇 |
2009年 | 8篇 |
2008年 | 7篇 |
2007年 | 9篇 |
2006年 | 9篇 |
2005年 | 3篇 |
2004年 | 4篇 |
2003年 | 8篇 |
2002年 | 6篇 |
2001年 | 6篇 |
2000年 | 5篇 |
1999年 | 11篇 |
1998年 | 12篇 |
1997年 | 17篇 |
1996年 | 9篇 |
1995年 | 8篇 |
1994年 | 17篇 |
1993年 | 18篇 |
1992年 | 13篇 |
1991年 | 13篇 |
1990年 | 10篇 |
1989年 | 8篇 |
1988年 | 8篇 |
1987年 | 9篇 |
1986年 | 10篇 |
1985年 | 11篇 |
1984年 | 14篇 |
1983年 | 11篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1980年 | 9篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1976年 | 3篇 |
1975年 | 5篇 |
1972年 | 2篇 |
1971年 | 5篇 |
排序方式: 共有406条查询结果,搜索用时 31 毫秒
71.
72.
73.
Sze Ue Luk Yung‐Tuen Chiu Davy TW Lee Stephanie Ma Terence Kin Wah Lee Raja S Vasireddy Yong‐Chuan Wong Yick Pang Ching Colleen Nelson Yee Leng Yap Ming‐Tat Ling 《International journal of cancer. Journal international du cancer》2011,128(9):2182-2191
Emerging evidence supports that prostate cancer originates from a rare subpopulation of cells, namely prostate cancer stem cells (CSCs). Conventional therapies for prostate cancer are believed to mainly target the majority of differentiated tumor cells but spare CSCs, which may account for the subsequent disease relapse after treatment. Therefore, successful elimination of CSCs may be an effective strategy to achieve complete remission from this disease. Gamma‐tocotrienols (γ‐T3) is one of the vitamin‐E constituents, which have been shown to have anticancer effects against a wide range of human cancers. Recently, we have reported that γ‐T3 treatment not only inhibits prostate cancer cell invasion but also sensitizes the cells to docetaxel‐induced apoptosis, suggesting that γ‐T3 may be an effective therapeutic agent against advanced stage prostate cancer. Here, we demonstrate for the first time that γ‐T3 can downregulate the expression of prostate CSC markers (CD133/CD44) in androgen‐independent prostate cancer cell lines (PC‐3 and DU145), as evident from Western blotting analysis. Meanwhile, the spheroid formation ability of the prostate cancer cells was significantly hampered by γ‐T3 treatment. In addition, pretreatment of PC‐3 cells with γ‐T3 was found to suppress tumor initiation ability of the cells. More importantly, although CD133‐enriched PC‐3 cells were highly resistant to docetaxel treatment, these cells were as sensitive to γ‐T3 treatment as the CD133‐depleted population. Our data suggest that γ‐T3 may be an effective agent in targeting prostate CSCs, which may account for its anticancer and chemosensitizing effects reported in previous studies. 相似文献
74.
Castonguay LG Nelson DL Boutselis MA Chiswick NR Damer DD Hemmelstein NA Jackson JS Morford M Ragusea SA Roper JG Spayd C Weiszer T Borkovec TD 《Psychotherapy (Chicago, Ill.)》2010,47(3):345-354
This paper describes the experiences of psychotherapists who, as part of a practice research network (PRN), collaborated with researchers in designing and conducting a psychotherapy study within their own clinical practices. A qualitative analysis of interviews conducted with these psychotherapists led to the delineation of several benefits (e.g., learning information that improved their work with clients and feeling that they were contributing to research that would be useful for psychotherapists) and difficulties for them and their clients (e.g., time and effort required to integrate research protocol into routine clinical practice) that psychotherapists associated with their participation in the PRN. Also identified were a number of strategies used by psychotherapists to address obstacles that they encountered, as well as general recommendations for future PRN studies. As a whole, the experiences of these psychotherapists are likely to provide valuable lessons for the survival and growth of what is viewed by many as a promising pathway for building a stronger bridge between practice and research. 相似文献
75.
The authors present the structure and process of a task force aimed at delineating empirically based principles of change in psychotherapy. Sponsored by Division 12 of the American Psychological Association and the North American Society for Psychotherapy Research, the task force addressed the potential role of participant characteristics, relationship variables, and technical factors in the treatment of dysphoric, anxiety, personality, and substance use disorders. 相似文献
76.
Vincent Castonguay Stephanie Lheureux Stephen Welch Helen J. Mackay Hal Hirte Gini Fleming R. Morgan Lisa Wang Chantale Blattler Percy S. Ivy Amit M. Oza 《Gynecologic oncology》2014
Objective
Treatment options remain limited for women with relapsed/metastatic endometrial cancer (EC). Angiogenesis is one of the major components of tumor progression and thus an attractive target. The aim of this phase II trial was to assess the efficacy and tolerability of sunitinib, an oral multitargeted receptor tyrosine-kinase inhibitor with antiangiogenic and antitumor activity in the treatment of recurrent EC.Methods
We performed a multicenter, single arm, two-stage phase II study of sunitinib, 50 mg daily administered on a 4 weeks on–2 weeks off schedule. Eligibility criteria included recurrent/metastatic EC or carcinosarcoma with no more than one prior line of chemotherapy. The primary endpoint was objective response rate.Results
34 women were enrolled; 33 received at least one dose of sunitinib and were included in the analyses. Six women (18.1%) had a partial response and six additional women (18.1%) stable disease. In total, ten patients (30.3%) had disease control for at least 6 months and of these, seven were controlled for more than one year. Median progression free and overall survival times were 3 months and 19.4 months, respectively. Adverse events related to treatment were frequent. At least one grade 3 toxicity occurred in 30 patients and dose reductions were required in 17 patients (52%). The most common grade 3 toxicities were fatigue, hypertension, palmar–plantar erythrodysesthesia, diarrhea and hematologic.Conclusion
Sunitinib therapy showed promising activity in women with recurrent EC. Toxicity was seen frequently but was manageable. Anti-angiogenic agents warrant further investigation in EC to define which patients will derive the greatest benefit. 相似文献77.
S Sahebjam P L Bedard V Castonguay Z Chen M Reedijk G Liu B Cohen W-J Zhang B Clarke T Zhang S Kamel-Reid H Chen S P Ivy A R A Razak A M Oza E X Chen H W Hirte A McGarrity L Wang L L Siu S J Hotte 《British journal of cancer》2013,109(4):943-949
Background:
The Notch signalling pathway has been implicated in tumour initiation, progression, angiogenesis and development of resistance to vascular endothelial growth factor (VEGF) targeting, providing a rationale for the combination of RO4929097, a γ-secretase inhibitor, and cediranib, a VEGF receptor tyrosine kinase inhibitor.Methods:
Patients received escalating doses of RO4929097 (on a 3 days-on and 4 days-off schedule) in combination with cediranib (once daily). Cycle 1 was 42 days long with RO4929097 given alone for the first 3 weeks followed by the co-administration of both RO4929097 and cediranib starting from day 22. Cycle 2 and onwards were 21 days long. Soluble markers of angiogenesis were measured in plasma samples. Archival tumour specimens were assessed for expression of three different components of Notch signalling pathway and genotyping.Results:
In total, 20 patients were treated in three dose levels (DLs). The recommended phase II dose was defined as 20 mg for RO4929097 on 3 days-on and 4 days-off schedule and 30 mg daily for cediranib. The most frequent treatment-related adverse events (AEs) were diarrhoea, hypertension, fatigue and nausea. Eleven patients had a best response of stable disease and one patient achieved partial response. We did not detect any correlation between tested biomarkers of angiogenesis or the Notch pathway and treatment effect. There was no correlation between mutational status and time to treatment failure.Conclusion:
RO4929097 in combination with cediranib is generally well tolerated at the DLs tested. Preliminary evidence of antitumour efficacy with prolonged disease stabilisation in some patients with progressive malignancies warrants further clinical investigation of this treatment strategy. 相似文献78.
79.
80.
A technique for the noninvasive diagnosis of pseudoaneurysms is described. This method employs in vivo labeling of red blood cells with Tc-99m to allow better delineation of the vascular anatomy than standard radionuclide angiography. Four cases are illustrated. 相似文献